PPC
CVS icon

Park Place Capital’s CVS Health CVS Stock Holding History

Park Place Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.1K Sell
878
-8
-0.9% -$616 0.01% 327
2025
Q4 		$70.3K Buy
886
+58
+7% +$4.57K 0.01% 282
2025
Q3 		$62.4K Buy
828
+15
+2% +$1.03K 0.01% 296
2025
Q2 		$56.6K Sell
813
-683
-46% -$44.8K 0.01% 332
2025
Q1 		$101K Sell
1,496
-8
-0.5% -$479 0.03% 260
2024
Q4 		$67.5K Sell
1,504
-449
-23% -$25.2K 0.02% 320
2024
Q3 		$123K Sell
1,953
-80
-4% -$4.67K 0.04% 264
2024
Q2 		$120K Buy
2,033
+311
+18% +$19.5K 0.04% 255
2024
Q1 		$137K Sell
1,722
-47
-3% -$3.59K 0.05% 280
2023
Q4 		$140K Sell
1,769
-866
-33% -$61.6K 0.06% 262
2023
Q3 		$184K Sell
2,635
-5,981
-69% -$424K 0.05% 242
2023
Q2 		$596K Sell
8,616
-4,467
-34% -$318K 0.17% 132
2023
Q1 		$972K Sell
13,083
-988
-7% -$82.8K 0.27% 82
2022
Q4 		$1.31M Buy
+14,071
New +$1.36M 0.37% 58

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Park Place Capital's CVS Position: Q1 2026 in Review

Park Place Capital reduced its CVS Health (CVS) stake by 0.9% in Q1 2026, selling an estimated $616 and leaving 878 shares worth $63.1K. The position accounts for 0.01% of the portfolio, ranked #327.

Park Place Capital first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.31M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Park Place Capital held 878 shares of CVS Health worth $63.1K as of Q1 2026.
  • Park Place Capital sold 8 CVS Health shares in Q1 2026, an estimated $616.
  • CVS Health made up 0.01% of Park Place Capital's portfolio in Q1 2026, its #327 holding.
  • Park Place Capital first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
  • Park Place Capital's CVS Health position peaked at $1.31M in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.